Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Hydrow is raising $25,075,612.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Bruce Smith played a key…
Boston, MA – According to filings with the U.S. Securities and Exchange Commission, Botkeeper is raising $25,000,006.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Enrico Palmerino played a key…
Newton, MA – According to filings with the U.S. Securities and Exchange Commission, Babel Bark is raising $2,250,000.00 in new funding. Sources indicate as part of senior management President, Roy Stein played a key role…
Boston, MA — Quartz Labs, Inc. has secured $1,500,000.00 in new commercial financing for expansion opportunities in Boston. According to the company website, We are software developers for hire. A core team, of makers and…
Boston, MA – According to filings with the U.S. Securities and Exchange Commission, Life Biosciences is raising $99,999,997.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Tristan Edwards played a…
Waltham, MA – According to filings with the U.S. Securities and Exchange Commission, jSonar is raising $50,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Ron Ben-Natan played a key…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Glympse Bio is raising $45,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Caroline Loew played a…
Lincoln, MA – According to filings with the U.S. Securities and Exchange Commission, OpenExchange is raising $6,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Mark Loehr played…
Lincoln, MA – According to filings with the U.S. Securities and Exchange Commission, OpenExchange is raising $6,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Mark Loehr played…
Boston, MA – According to filings with the U.S. Securities and Exchange Commission, Inozyme Pharma is raising $67,399,993.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Axel Bolte played a…